1Galie N,Hoeper MM,Humbert M. Guidelines for the diagnosis and treatnent of pulnonary hypertension:the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].European Heart Journal,2009,(20):2493-2537.
5Miyagawa K, Emoto N. A new class of drug for pulmonary arterial hypertension [J]. Circ J, 2013, 77(10): 2477-2478.
6Puri A, McGoon M D, Kushwaha S S. Pulmonary arterial hypertension: current therapeutic strategies [J]. Nat Clin P+/ract Cardiovasc Med, 2007, 4(6): 319-329.
8Higgins J P T, Green S. Cochrane handbook for systematic reviews of interventions [OL]. [2011-03-17]. http://handbook.cochrane.org/.
9Raja S G. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension [J]. Recent Pat Cardiovasc Drug Discov, 2012, 7(2): 100-104.
